Search for: "Myers, Appeal of"
Results 341 - 360
of 1,418
Sort by Relevance
|
Sort by Date
30 Mar 2019, 8:49 pm
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Standing to Appeal from the PTAB" on April 4, 2019 from 2:00 to 3:00 pm (ET). [read post]
28 Mar 2019, 4:00 am
In Myers v. [read post]
26 Mar 2019, 8:22 pm
“Bristol-Myers, Pfizer defeat Eliquis bleeding risk lawsuits on appeal”: Nate Raymond of Reuters has this report (subscription required for full access) on a ruling that the U.S. [read post]
18 Mar 2019, 5:52 pm
Of course, the state could also appeal to the Ninth Circuit, but I think it will lose if it does so. [read post]
15 Mar 2019, 9:17 am
Serving West Palm Beach, Miami, Tampa, Orlando and Fort Myers/ Naples. [read post]
13 Mar 2019, 10:18 am
Court of Appeals for the Ninth Circuit. [read post]
13 Mar 2019, 10:18 am
Court of Appeals for the Ninth Circuit. [read post]
13 Mar 2019, 2:55 am
” (quoting Myers v. [read post]
12 Mar 2019, 5:50 pm
The record is not searched for an alternative basis to affirm.In Myers v. [read post]
11 Mar 2019, 7:08 pm
Bristol-Myers Squibb Co. [read post]
11 Mar 2019, 1:03 pm
Should the motion be denied, consideration of a request for interlocutory appeal under 28 U.S.C. [read post]
7 Mar 2019, 7:05 am
The company dropped an appeal of a twice-upheld decision that it owed three drivers benefits. [read post]
5 Mar 2019, 7:27 am
The Third Circuit joined with the Second Circuit in Myers v. [read post]
1 Mar 2019, 5:15 am
Bristol-Myers Squibb Co., No. 2017-1694, 2019 U.S. [read post]
27 Feb 2019, 9:59 am
Serving West Palm Beach, Miami, Tampa, Orlando and Fort Myers/ Naples. [read post]
14 Feb 2019, 4:30 pm
Yes, according to the Indiana Supreme Court decision in Myers v. [read post]
12 Feb 2019, 7:56 pm
Bristol-Myers Squibb Co. [read post]
7 Feb 2019, 8:55 pm
Noonan -- The Federal Circuit has on several occasions taken the opportunity to address (and in doing so, flesh out) the requirements for Article III standing to appeal an adverse determination in a post-grant review proceeding (post-grant review, inter partes review, and covered business method patent review) against a Petitioner (loss of patent claims typically provides sufficient injury for a Patent Owner to have standing). [read post]
7 Feb 2019, 5:36 pm
Bristol-Myers Squibb Co. [read post]
7 Feb 2019, 6:37 am
IPR2018-01154 targeting claims 15-20 of the U.S. envelope tracker patent is most interesting in this regard as the claims and the prior art references are most similar to the issues before the EPO's opposition division.The Patent Trial and Appeal Board (PTAB) of the United States Patent & Trademark Office (USPTO), which had previously instituted two inter partes reviews of the envelope tracker patent, yesterday granted two more petitions, resulting in a total of four IPRs targeting… [read post]
